Product Recalls in Florida

Product recalls affecting Florida — including food, drugs, consumer products, medical devices, and vehicles distributed to Florida. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,939 recalls have been distributed to Florida in the last 12 months.

55,837 total recalls
2,939 in last 12 months

Showing 21212140 of 13,925 recalls

DrugMarch 13, 2023· Direct Rx

Recalled Item: Montelukast Sodium Tablets Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Simvastatin Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 10, 2023· Noven Pharmaceuticals Inc

Recalled Item: Daytrana (methylphenidate transdermal system) CII Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 10, 2023· Noven Pharmaceuticals Inc

Recalled Item: Daytrana (methylphenidate transdermal system) CII Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 10, 2023· Noven Pharmaceuticals Inc

Recalled Item: Daytrana (methylphenidate transdermal system) CII Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 10, 2023· Noven Pharmaceuticals Inc

Recalled Item: Daytrana (methylphenidate transdermal system) CII Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 9, 2023· Boehringer Ingelheim Pharmaceuticals, Inc.

Recalled Item: JARDIANCE (Empagliflozin) Recalled by Boehringer Ingelheim Pharmaceuticals,...

The Issue: Labeling: Label Mix-up

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 9, 2023· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Dofetilide Capsules Recalled by SUN PHARMACEUTICAL INDUSTRIES INC Due to...

The Issue: Failed Content Uniformity Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 8, 2023· Pfizer Inc.

Recalled Item: MEKTOVI (binimetinib) tablets Recalled by Pfizer Inc. Due to Labeling:...

The Issue: Labeling: Incorrect or Missing Lot and/or Exp Date: The carton and bottle...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 2, 2023· Endo Pharmaceuticals, Inc.

Recalled Item: Calcitonin Salmon Nasal Spray Recalled by Endo Pharmaceuticals, Inc. Due to...

The Issue: Failed Impurities/Degradation Specifications and Subpotent Drug: High Out of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 2, 2023· Breckenridge Pharmaceutical, Inc

Recalled Item: Alprazolam Tablets Recalled by Breckenridge Pharmaceutical, Inc Due to CGMP...

The Issue: CGMP Deviations: Potential risk of Cross Contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 2, 2023· Breckenridge Pharmaceutical, Inc

Recalled Item: Alprazolam Tablets Recalled by Breckenridge Pharmaceutical, Inc Due to CGMP...

The Issue: CGMP Deviations: Potential risk of Cross Contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 2, 2023· Breckenridge Pharmaceutical, Inc

Recalled Item: Alprazolam Tablets Recalled by Breckenridge Pharmaceutical, Inc Due to CGMP...

The Issue: CGMP Deviations: Potential risk of Cross Contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 2, 2023· Breckenridge Pharmaceutical, Inc

Recalled Item: Alprazolam Tablets Recalled by Breckenridge Pharmaceutical, Inc Due to CGMP...

The Issue: CGMP Deviations: Potential risk of Cross Contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 2, 2023· Breckenridge Pharmaceutical, Inc

Recalled Item: Clobazam Tablets Recalled by Breckenridge Pharmaceutical, Inc Due to CGMP...

The Issue: CGMP Deviations: Potential risk of Cross Contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 2, 2023· Breckenridge Pharmaceutical, Inc

Recalled Item: Clobazam Tablets Recalled by Breckenridge Pharmaceutical, Inc Due to CGMP...

The Issue: CGMP Deviations: Potential risk of Cross Contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 1, 2023· B. Braun Medical Inc

Recalled Item: Heparin Sodium Recalled by B. Braun Medical Inc Due to Subpotent Drug: low...

The Issue: Subpotent Drug: low Anti-Factor IIa potency.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 1, 2023· Apotex Corp.

Recalled Item: Brimonidine Tartrate Ophthalmic Solution 0.15% Recalled by Apotex Corp. Due...

The Issue: Lack of sterility assurance: Cracks have developed in some of the units caps...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2023· Sagent Pharmaceuticals Inc

Recalled Item: Heparin Sodium Injection Recalled by Sagent Pharmaceuticals Inc Due to...

The Issue: Labeling: Not elsewhere classified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 24, 2023· Global Pharma Healthcare Private Limited

Recalled Item: Delsam Pharma's Artificial Eye Ointment (Mineral Oil 15% Recalled by Global...

The Issue: Non-Sterility: FDA analysis found unopened tubes to be contaminated with...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund